Japan, Jan. 16 -- NANSHA BIOLOGICS (HONG KONG) LTD has got intellectual property rights for 'REACTIVE INTERMEDIATE FOR GENERATING POLYETHYLENE GLYCOL (PEG)-INTERLEUKIN 11 (IL-11) CONJUGATE, AND METHOD FOR PURIFYING PEG-IL-11 CONJUGATE.' Other related details are as follows:
Application Number: JP,2021-120139
Category (FI): A61K38/20,A61K47/60,A61P1/00,A61P1/04,A61P11/00,A61P19/08,A61P29/00,A61P43/00,111,A61P7/04,A61P9/00,C07K1/18,C07K14/54,C12N15/10,200@Z
Stage: Grant (IP right granted following substantive examination.)
Filing Date: July 21, 2021
Publication Date: Nov. 11, 2021
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
